Vertex Pharmaceuticals (VRTX) has outperformed the market over the past 15 years by 4.73% on an annualized basis producing an average annual return of 17.22%. Currently, Vertex Pharmaceuticals has a ...

Vertex Pharmaceuticals Incorporated just reported a robust Q2 with earnings per share of $4.52, surpassing estimates and ...

Vertex Pharmaceuticals Incorporated made headlines with a notable investment by Alaethes Wealth LLC, which scooped up 3,051 ...

We offer a range of undergraduate and postgraduate degree programmes which combine the highest levels of traditional scholarship with innovative approaches to our core interests in language, ...